| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1985) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent Prodrug |
| UNII: | 9O25354EPJ |
| InChI Key | OYFJQPXVCSSHAI-QFPUQLAESA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C24H32N2O9 |
| Molecular Weight | 492.53 |
| AlogP | 1.6 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 95.94 |
| Molecular species | ACID |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 27.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Angiotensin-converting enzyme inhibitor | FDA |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 111 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Proteinuria | 3 | D011507 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Cerebral Hemorrhage | 2 | D002543 | ClinicalTrials |
| Pre-Eclampsia | 2 | D011225 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 4785 |
| ChEMBL | CHEMBL1200659 |
| EPA CompTox | DTXSID30896796 |
| FDA SRS | 9O25354EPJ |
| Guide to Pharmacology | 6322 |
| KEGG | C06977 |
| PubChem | 5388961 |
| SureChEMBL | SCHEMBL9 |